diagnostics development

AlpaCure's mission is to revolutionize TB diagnostics by developing effective and user-friendly solutions that are affordable and accessible, particularly for economically disadvantaged communities. AlpaCure harnesses the alpaca immune system, combining it with advanced machine learning and synthetic biology, to engineer ultrapotent antibody fragments for next-generation diagnostic applications.

antibody fragment engineeringmachine learningsynthetic biology

Arterez, Inc. is a Michigan biosciences group focused on the discovery and development of therapeutics and diagnostics against chronic vascular diseases, beginning with cardiovascular disease (CVD), by targeting upstream multifactorial root causes. Its platform involves proprietary combo therapies and multi-marker diagnostics addressing disruption of the endothelial glycocalyx.

biomarker panel developmentpreclinical studiestherapeutics discovery and development

Aurora Oncology is a pre-clinical biotechnology start-up created by scientists and physicians at the University of Colorado Anschutz Medical Campus and Boulder Campus. It is dedicated to developing drugs and diagnostics to treat bladder cancer, bringing discoveries from the research bench to patients with targetable tumors. The company is a member of the SPARK program and has received funding from NIH, the State of Colorado, and CU Innovations.

drug developmenttargeted therapytheranosticsthermal ablation

BioIncept, a wholly owned subsidiary of Prince Biotech, is a clinical-stage biotechnology company developing breakthrough therapeutics and diagnostics built on its proprietary discovery of the PreImplantation Factor (PIF). The company is advancing novel therapies in regenerative medicine, immune modulation, and reproductive health, focused on improving IVF outcomes and tackling conditions such as autoimmunity and neuro-regeneration.

immune modulationregenerative medicinereproductive healththerapeutics development

CIAN, Inc. is a Delaware-incorporated start-up company founded by Professor Ramchandran in March 2023 and based in Wisconsin. It develops biomarkers based on ciliary proteins found in blood to inform changes in blood flow associated with disease, aiming for point-of-care testing that diagnoses disease severity and prognosticates outcomes. The technology stems from research at the Medical College of Wisconsin on cilia loss from endothelial cells under turbulent flow (deciliation).

biomarker developmentresearch on cilia in brain blood vessel developmenttherapeutic development

CLEU Diagnostics is a diagnostics company developing the LabSimple platform, described as a generational leap in diagnostics now in the palm of your hand. The company was one of the first companies founded and incubated at Parvizi Surgical Innovation. Its leadership includes physicians, scientists, and diagnostics industry veterans.

assay developmentdesign for manufacturabilityinstrument designmicrofluidicsquality assurance for IVD productssystem integration

Cor Dx partners with organizations around the world to develop, manufacture, and supply diagnostics that empower users to monitor and improve their health.

diagnostics manufacturingdiagnostics supply